Long-term follow-up of an alemtuzumab (CAMPATH-1H) containing reduced intensity allogeneic transplant regimen for non-Hodgkin's lymphoma (NHL).

被引：0
|
作者：
Morris, E
Thomson, K
Craddock, C
Milligan, D
Smith, GM
Parker, A
Schey, S
Winfield, D
Chopra, R
Littlewood, T
Tighe, J
Hunter, A
Kyriakou, C
Kottaridis, P
Peggs, K
Linch, D
Goldstone, A
Mackinnon, S
机构：
来源：
BLOOD | 2002年 / 100卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
139
引用
收藏
页码：40A / 40A
页数：1
相关论文
共 50 条
  • [21] THE NON-HODGKIN LYMPHOMA PATHOLOGIC CLASSIFICATION PROJECT - LONG-TERM FOLLOW-UP OF 1153 PATIENTS WITH NON-HODGKIN LYMPHOMAS
    SIMON, R
    DURRLEMAN, S
    HOPPE, RT
    BONADONNA, G
    BLOOMFIELD, CD
    RUDDERS, RA
    CHESON, BD
    BERARD, CW
    ANNALS OF INTERNAL MEDICINE, 1988, 109 (12) : 939 - 945
  • [22] Prognostic factors and long follow-up in non-Hodgkin's lymphoma
    Llanos, M
    Cruz, J
    Oramas, J
    Aleman, R
    Dorta, J
    Morales, M
    Batista, N
    ANNALS OF ONCOLOGY, 1998, 9 : 110 - 111
  • [23] Quality of Life Among Long-Term Survivors of Non-Hodgkin Lymphoma: A Follow-Up Study
    Smith, Sophia K.
    Mayer, Deborah K.
    Zimmerman, Sheryl
    Williams, Christianna S.
    Benecha, Habtamu
    Ganz, Patricia A.
    Edwards, Lloyd J.
    Abernethy, Amy P.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (02) : 272 - 279
  • [24] Long-term follow-up of non-Hodgkin's lymphoma patients treated with ProMACE-CytaBOM: an effective regimen for the intermediate grade subtype
    Marotta, G
    Bigazzi, C
    Bocchia, M
    Forconi, F
    Lauria, F
    HAEMATOLOGICA, 1998, 83 (09) : 853 - 854
  • [25] Feasibility of allogeneic hematopoietic stem cell transplantation (HSCT) with a reduced-intensity (RI) conditioning regimen for non-Hodgkin's lymphoma (NHL).
    Kusumi, E
    Tanimoto, TE
    Kami, M
    Hamaki, T
    Yuji, K
    Ueyama, J
    Miyakoshi, S
    Morinaga, S
    Kanda, Y
    Makimoto, A
    Kataoka, I
    Kim, SW
    Ohnishi, M
    Nakai, K
    Tobinai, K
    Tanosaki, R
    Mineishi, S
    Takaue, Y
    Mutou, Y
    BLOOD, 2001, 98 (11) : 377B - 377B
  • [26] Stage I and II follicular non-Hodgkin's lymphoma: Long-term follow-up of no initial therapy
    Advani, R
    Rosenberg, SA
    Horning, SJ
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (08) : 1454 - 1459
  • [27] Long-term follow-up of reduced intensity allogeneic haematopoietic stem cell transplantation in follicular lymphoma
    Meireles, S.
    Branca, R.
    Pinho Vaz, C.
    Campilho, F.
    Rosales, M.
    Roncon, S.
    Campos, A.
    BONE MARROW TRANSPLANTATION, 2013, 48 : S426 - S426
  • [28] Reduced-intensity rituximab-BEAM-CAMPATH allogeneic transplantation for indolent non-Hodgkin's lymphoma.
    Ho, AYL
    Devereux, S
    Mufti, GL
    Pagliuca, A
    BLOOD, 2001, 98 (11) : 188A - 188A
  • [29] Long-term follow up of patients with relapsed non-Hodgkin lymphoma receiving allogeneic stem cell transplantation
    Link, C.
    Mies, F.
    Kramer, M.
    Schetelig, J.
    Haenel, M.
    Bornhaeser, M.
    Ehninger, G.
    Kroschinsky, F.
    ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 132 - 132
  • [30] A long-term follow-up of 33 patients with non-Hodgkin's lymphoma who received the BEAM high-dose intensification regimen with cytokine support only and no transplant
    J Ph Laporte
    M Yeshurun
    L Fouillard
    M Labopin
    C Cailliot
    S Lesage
    F Isnard
    A Najman
    N-C Gorin
    Leukemia, 2004, 18 : 1717 - 1721
12345